The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients with Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study.
Frontiers in Oncology（2021）
Key words
apatinib,camrelizumab (SHR-1210),advanced biliary tract cancer,combination therapy,PD-1,L1 blockade,target therapy,immunotherapy,cholangiocarcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined